SVF Endurance (Cayman) Ltd, 10% Owner at Vir Biotechnology, Inc. (VIR), sold 467,998 shares at $25.94 ($12.3M) on 2023-02-10, disclosed to the SEC on 2023-02-13.
Open-market sale of $12.3M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.99 | 544 | $14K | 0.1% |
| 2 | $26.33 | 127,016 | $3.3M | 27.2% |
| 3 | $26.33 | 127,016 | $3.3M | 27.2% |
| 4 | $27.17 | 9,490 | $258K | 2.1% |
| 5 | $27.17 | 9,490 | $258K | 2.1% |
| 6 | $25.94 | 12,813 |
| $332K |
| 2.7% |
| 7 | $25.94 | 12,813 | $332K | 2.7% |
| 8 | $26.16 | 84,408 | $2.2M | 18.0% |
| 9 | $26.16 | 84,408 | $2.2M | 18.0% |
| Total | $26.28 avg | 467,998 | $12.3M | 100% |
| Filing → |
| VIR | SELL | 2025-10-30 | $319K | — | Filing → |
| VIR | SELL | 2025-10-22 | $2.7M | — | Filing → |
| VIR | SELL | 2025-10-17 | $359K | — | Filing → |